Los Angeles, California, United States Kite Pharma is the famous Corporate Investor, which was founded in 2009. The main office of represented Corporate Investor is situated in the Los Angeles. The company was established in North America in United States.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2017.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Kite Pharma, startups are often financed by Nest.Bio Ventures, Viventures, Utrecht Holdings. The meaningful sponsors for the fund in investment in the same round are VI Ventures, Two River, Sequoia Capital China.
Among the most popular fund investment industries, there are Health Care, Medical. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight HiFiBiO, Gadeta, Cell Design Labs. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
This organization was formed by Arie Belldegrun, Joshua A. Kazam.
Related Funds
| Fund Name | Location |
| CHC Capital | Beijing, Beijing Shi, China |
| Grey Sky Venture Partners | - |
| Inseed Investimentos | Belo Horizonte, Brazil, Minas Gerais |
| Jane Street Capital | New York, New York, United States |
| Meritz Real Estate Asset Management | Seoul, Seoul-t'ukpyolsi, South Korea |
| NBCi | California, San Francisco, United States |
| NextProtocol Ventures | - |
| Norwich Ventures | Cambridge, Massachusetts, United States |
| Silver Point Capital, L.P. | Connecticut, Greenwich, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ensoma | $50M | 16 May 2023 | Boston, Massachusetts, United States | ||
Shoreline Biosciences | $140M | 02 Nov 2021 | San Diego, California, United States | ||
| $80M | 24 Feb 2021 | Cambridge, Massachusetts, United States | |||
Shoreline Biosciences | $43M | 07 Feb 2021 | San Diego, California, United States | ||
Vineti | $35M | 05 Feb 2020 | San Francisco, California, United States | ||
HiFiBiO | $67M | 28 Aug 2019 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ensoma | $50M | 16 May 2023 | Boston, Massachusetts, United States | ||
Shoreline Biosciences | $140M | 02 Nov 2021 | San Diego, California, United States | ||
| $80M | 24 Feb 2021 | Cambridge, Massachusetts, United States | |||
Shoreline Biosciences | $43M | 07 Feb 2021 | San Diego, California, United States | ||
Vineti | $35M | 05 Feb 2020 | San Francisco, California, United States | ||
HiFiBiO | $67M | 28 Aug 2019 | Paris, Ile-de-France, France |
